Fulgent Genetics, Inc. cotiza a 21.46 USD y tiene una capitalización bursátil de $590M. En los últimos 12 meses ha facturado $324M con un margen de flujo de caja libre del -38.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such…
| Periodo | 2026-11 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.58 | $-0.36 | $0.16 |
| Estimado | $-0.65 | $-0.44 | $-0.35 | $0.03 |
| Sorpresa | — | -31.8% | -2.9% | +433.3% |
| Métrica | FLGT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 40.6% | 57.0% | -16.5% |
| Operating Margin | -28.2% | -38.6% | +10.4% |
| Net Margin | -18.8% | -33.6% | +14.8% |
| FCF Margin | -38.5% | -13.9% | -24.6% |
| ROE | -5.4% | -40.4% | +35.0% |
| ROA | -5.0% | -32.0% | +27.0% |
| Current Ratio | 6.48 | 2.84 | +3.64 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |